The present invention relates to novel arylsulphonamides and analogues, to processes for their preparation and to their use for the prophylaxis and treatment of neurodegenerative disorders, in particular for the treatment of cerebral apoplexy, craniocerebral trauma, pain and spasticity.
Claims What is claimed is: 1. Compounds of the general formula (I) in which R.sup.1 represents a radical of the formula ##STR44## in which the ring systems listed above are optionally substituted, optionally geminally, by one or more identical or different substituents selected from the group consisting of: halogen, carboxyl, hydroxyl, phenyl, (C.sub.1 -C.sub.6)-alkoxy, (C.sub.1 -C.sub.6)-alkoxycarbonyl, (C.sub.1 -C.sub.8)-alkyl, which for its part may be substituted by halogen, (C.sub.1 -C.sub.6)-alkylsulphonyloxy, azide, amino, mono(C.sub.1 -C.sub.6)-alkylamino, di(C.sub.1 -C.sub.6)-alkylamino or hydroxyl, a group of the formula --(CO).sub.b -NR.sup.4 R.sup.5, in which b represents a number 0 or 1, R.sup.4 and R.sup.5 are identical or different and independently of one another represent hydrogen, phenyl, (C.sub.1 -C.sub.6)-acyl, cyclo(C.sub.4 -C.sub.7)-acyl benzoyl or (C.sub.1 -C.sub.6)-alkyl, which is optionally substituted by amino, mono(C.sub.1 -C.sub.6)-alkylamino, di(C.sub.1 -C.sub.6)-alkylamino, or R.sup.4 and R.sup.5 together with the nitrogen atom form a 5- or 6-membered saturated heterocycle which may optionally contain one or more further heteroatom(s) from the group consisting of S and O and/or one or more radical(s) of the formula --NR.sup.8, in which R.sup.8 represents hydrogen, (C.sub.1 -C.sub.6)-alkyl or (C.sub.1 -C.sub.6)-acyl, and a group of the formula --NR.sup.6 --SO.sub.2 --R.sup.7 in which and R.sup.6 represents hydrogen, phenyl, (C.sub.1 -C.sub.6)-alkyl or (C.sub.1 -C.sub.6)-acyl, R.sup.7 represents phenyl or (C.sub.1 -C.sub.6)-alkyl, and a radical of the formula ##STR45## in which c represents a number 1, 2, 3, 4, 5 or 6, R.sup.9 and R.sup.10 are identical or different and represent hydrogen or (C.sub.1 -C.sub.6)-alkyl, T represents a radical of the formula --(CH.sub.2).sub.d --, in which d represents a number 1, 2, 3, 4, 5 or 6, or T represents a moiety of an amino acid radical of the formula ##STR46## in which R.sup.13 and R.sup.14 are identical or different and represent hydrogen or methyl, or R.sup.13 represents hydrogen or methyl and R.sup.14 represents (C.sub.3 -C.sub.8)-cycloalkyl or (C.sub.6 -C.sub.10)-aryl or hydrogen, or (C.sub.1 -C.sub.8)-alkyl, where the (C.sub.1 -C.sub.8)-alkyl is optionally substituted by methlythio, hydroxyl, mercapto, guanidyl or by a group of the formula --NR.sup.15 R.sup.16 or --NR.sup.17 --OC--, in which R.sup.15 and R.sup.16 independently of one another represent hydrogen, (C.sub.1 -C.sub.8)-alkyl or phenyl and R.sup.17 represents hydroxyl, benzyloxy, (C.sub.1 -C.sub.8)-alkoxy or the group --NR.sup.15 R.sup.16 listed above, or the (C.sub.1 -C.sub.8)-alkyl is optionally substituted by (C.sub.3 -C.sub.6)-cycloalkyl or phenyl, which for its part is substituted by hydroxyl, halogen or (C.sub.1 -C.sub.6)-alkoxy or amino, or the (C.sub.1 -C.sub.8)-alkyl is optionally substituted by imidazolyl or indolyl, in which the corresponding --NH functions are optionally protected by (C.sub.2 -C.sub.6)-alkyl or by an amino protective group, R.sup.11 and R.sup.12 are identical or different and represent hydrogen, (C.sub.1 -C.sub.6)-alkyl or a typical amino protective group, or R.sup.11 and R.sup.12 together with the nitrogen atom form a 5-to 6-membered saturated heterocycle, which may optionally contain a further heteroatom from the group consisting of S and O or a radical of the formula --NR.sup.18, in which R.sup.18 represents hydrogen, (C.sub.1 -C.sub.6)-alkyl or phenyl, A and E D represents an oxygen atom or represents a radical of the formula --S(O).sub.e -- or --N(R.sup.19)--, in which e represents a number 0, 1 or 2, R.sup.19 represents hydrogen, (C.sub.1 -C.sub.6)-alkyl or (C.sub.1 -C.sub.6)-acyl, G represents doubly attached (C.sub.6 -C.sub.10)-aryl which is optionally substituted by one or more identical or different substituents selected from the group consisting of: hydroxyl, trifluoromethyl, carboxyl, halogen, (C.sub.1 -C.sub.6)-alkyl, hydroxy(C.sub.1 -C.sub.6)-alkyl, (C.sub.1 -C.sub.6)-alkoxy, (C.sub.1 -C.sub.6)-alkoxycarbonyl, and groups of the formulae --CO--O--(CH.sub.2).sub.f --NR.sup.20 R.sup.21, --NR.sup.22 --SO.sub.2 R.sup.23, --(CH.sub.2).sub.g --(CO).sub.h --NR.sup.24 R.sup.25 and --OR.sup.26, in which f represents a number 1, 2, 3 or 4, g and h are identical or different and represent a number 0 or 1, R.sup.20 and R.sup.21 have the meaning of R.sup.4 and R.sup.5 given above, R.sup.22 has the meaning of R.sup.6 given above, R.sup.23 has the meaning of R.sup.7 given above, R.sup.24 and R.sup.25 have the meaning of R.sup.4 and R.sup.5 given above, or independently of one another represent a radical of the formula --(CH.sub.2).sub.i --NR.sup.27 R.sup.28, in which i represents a number 1, 2, 3 or 4, and R.sup.27 R.sup.28 have the meaning of R.sup.4 and R.sup.5 given above, R.sup.26 represents (C.sub.6 -C.sub.10)-aryl, L represents a radical of the formula, ##STR47## where the left-hand side of the radicals is attached to G, R.sup.2 represents (C.sub.6 -C.sub.10)-aryl or represents a 5- to 7-membered saturated or aromatic heterocycle having up to 3 heteroatoms from the group consisting of S, N and O, which are optionally substituted by one or more identical or different substituents selected from the group consisting of: halogen, trifluoromethyl, nitro, amino and (C.sub.1 -C.sub.6)-alkyl, or represents the radical of the formula ##STR48## or morpholine, or represents C.sub.3 -C.sub.8 -cycloalkyl, or represents (C.sub.1 -C.sub.12)-alkyl, (C.sub.2 -C.sub.12)-alkenyl or (C.sub.2 -C.sub.12)-alkinyl, which are optionally substituted by one or more identical or different substituents selected from the group consisting of: halogen, trifluoromethyl, hydroxyl, cyano, azido, (C.sub.1 -C.sub.6)-alkoxy, (C.sub.1 -C.sub.6)-perfluoroalkoxy, partially fluorinated (C.sub.1 -C.sub.6)-alkoxy, a radical of the formula ##STR49## in which R.sup.38 and R.sup.39 have the meaning of R.sup.4 and R.sup.5 given above, phenyl, optionally substituted by one or more identical or different substituents selected from the group consisting of: halogen, nitro, hydroxyl, (C.sub.1 -C.sub.6)-alkyl, (C.sub.1 -C.sub.6)-alkoxy and a group of the formula --NR.sup.40 R.sup.41, in which R.sup.40 and R.sup.41 are identical or different and represent hydrogen or (C.sub.1 -C.sub.6)-alkyl or (C.sub.1 -C.sub.6)-acyl, and a 5- to 6-membered aromatic heterocycle having up to three heteroatoms from the group consisting of S, N and O, optionally substituted by one or more identical or different substituents selected from the group consisting of: halogen, nitro, hydroxyl, (C.sub.1 -C.sub.6)-alkyl, (C.sub.1 -C.sub.6)-alkoxy and a group of the formula --NR.sup.40 R.sup.41 in which R.sup.40 and R.sup.41 are as defined above, or L and R.sup.2 together represent a radical of the formula ##STR50## and pharmaceutically acceptable salts thereof, with proviso that R.sup.1 does not represent an unsubstituted radical. 2. Compounds of the general formula (I) according to claim 1, R.sup.1 represents a radical of the formula ##STR51## and where the ring systems listed above are optionally substituted, optionally geminally, by one or more identical or different substituents selected from the group consisting of: fluorine, chlorine, carboxyl, hydroxyl, (C.sub.1 -C.sub.4)-alkoxy, (C.sub.1 -C.sub.5)-alkoxycarbonyl or (C.sub.1 -C.sub.6)-alkyl, which for its part may be substituted by fluorine, chlorine or hydroxyl, and a radical of the formula ##STR52## in which c represents a number 1, 2, 3, 4, 5 or 6, R.sup.9 and R.sup.10 are identical or different and represent hydrogen or (C.sub.1 -C.sub.6)-alkyl, T represents a radical of the formula --(CH.sub.2).sub.d --, in which d represents a number 1, 2, 3, 4, 5 or 6, or T represents a moiety of an amino acid radical of the formula ##STR53## in which R.sup.13 and R.sup.14 are identical or different and represent hydrogen or (C.sub.1 -C.sub.6)-alkyl, or R.sup.13 represents hydrogen or methyl and R.sup.14 represents cyclopropyl, cyclopentyl, cyclohexyl, phenyl or hydrogen, or represents (C.sub.1 -C.sub.6)-alkyl, where the (C.sub.1 -C.sub.6)-alkyl is optionally substituted by methlythio, hydroxyl, mercapto, guanidyl or by a group of the formula --NR.sup.15 R.sup.16 or --NR.sup.17 --OC--, in which R.sup.15 R.sup.16 independently of one another represent hydrogen, (C.sub.1 -C.sub.6)-alkyl or phenyl and R.sup.17 represents hydroxyl, benzyloxy, (C.sub.1 -C.sub.6)-alkoxy or the group --NR.sup.15 R.sup.16 listed above, or the (C.sub.1 -C.sub.6)-alkyl is optionally substituted by cyclopropyl, cyclopentyl, cyclohexyl or phenyl, which for its part is substituted by hydroxyl, fluorine, chlorine, bromine or (C.sub.1 -C.sub.4)-alkoxy or amino, or R.sup.11 and R.sup.12 are identical or different and represent hydrogen or (C.sub.1 -C.sub.4)-alkyl, or R.sup.11 and R.sup.12 together with the nitrogen atom form a morpholinyl piperidinyl or piperazinyl ring, A and E, D represents an oxygen atom, G represents doubly attached phenyl or pyridyl, which are optionally substituted by one or more identical or different substituents selected from the group consisting of: hydroxyl, trifluoromethyl, carboxyl, halogen, (C.sub.1 -C.sub.4 -alkyl, hydroxy(C.sub.1 -C.sub.4)alkyl, (C.sub.1 -C.sub.4)-alkoxy, (C.sub.1 -C.sub.4)-alkoxycarbonyl and groups of the formulae --CO--O--(CH.sub.2).sub.f --NR.sup.20 R.sup.21, --NR.sup.22 --SO.sub.2 R.sup.23, --(CH.sub.2)g--(CO).sub.h -- NR.sup.24 R.sup.25 and OR.sup.26, in which f represents a number 1, 2, 3 or 4, g and h are identical or different and represent a number 0 or 1, R.sup.20 and R.sup.21 have the meaning of R.sup.4 and R.sup.5 given above, R.sup.22 has the meaning of R.sup.6 given above, R.sup.23 has the meaning of R.sup.7 given above, R.sup.24 and R.sup.25 have the meaning of R.sup.4 and R.sup.5 given above, or independently of one another represent a radical of the formula --(CH.sub.2).sub.i --NR.sup.27 R.sup.28, in which i represents a number 1, 2 or 3, and R.sup.27 and R.sup.28 have the meaning of R.sup.20 and R.sup.21 given above, R.sup.26 represents phenyl or naphthyl, L represents a radical of the formula ##STR54## where the left-hand side of the radicals is attached to G, R.sup.2 represents (C.sub.1 -C.sub.1 o)-alkyl which is optionally substituted more identical or different substituents selected from the group consisting of: fluorine, chlorine, bromine, phenyl, trifluoromethyl, hydroxyl, azido, (C.sub.1 -C.sub.4)-alkoxy, (C.sub.1 -C.sub.5)-perfluoroalkoxy or partially fluorinated (C.sub.1 -C.sub.4)alkoxy and pharmaceutically acceptable salts thereof. 3. Compounds of the general formula (I), according to claim 1 in which R.sup.1 represents a radical of the formula ##STR55## and where the ring systems listed above are optionally substituted by one or more identical or different substituents selected from the group consisting of: chlorine, fluorine, hydroxyl, (C.sub.1 -C.sub.3)-alkoxy or (C.sub.1 -C.sub.4)-alkyl, which for its part may be substituted by hydroxyl, A and E represent a bond, D represents an oxygen atom, G represents doubly attached phenyl which are optionally substituted by one or more identical or different substituents selected from the group consisting of: hydroxyl, trifluoromethyl, carboxyl, fluorine, chlorine, bromine, (C.sub.1 -C.sub.3)-alkyl, hydroxy(C.sub.1 -C.sub.3)alkyl or (C.sub.1 -C.sub.3)-alkoxy L represents a radical of the formula ##STR56## where the left-hand side of the radicals is attached to G, R.sup.2 represents (C.sub.1 -C.sub.8)-alkyl, which is optionally substituted by one or more identical or different substituents selected from the group consisting of: fluorine, chlorine, bromine, phenyl, trifluoromethyl or trifluoromethyl-substituted (C.sub.1 -C.sub.4)-alkoxy, and pharmaceutically acceptable salts thereof. 4. Compounds of the general formula (I), according to claim 1, in which R.sup.1 represents a radical of the formula ##STR57## A and E represent bonds, D represents an oxygen atom, G represents doubly attached phenyl, which is optionally substituted by fluorine, chlorine or bromine, L represents a radical of the formula ##STR58## where the left-hand side of the radical is attached to G, R.sup.2 represents (C.sub.1 -C.sub.4)-alkyl, which is optionally substituted by fluorine or trifluoromethyl, and pharmaceutically acceptable salts thereof. 5. Compounds selected from the group consisting of ##STR59## 6. A process for preparing novel arylsulphonamides and analogues according to claim 1, characterized in that [A] compounds of the general formula (IV) 7. A pharmaceutical composition which comprises, as an active component, at least one compound according to claim 1 in combination with at least one pharmaceutically acceptable essentially non-toxic vehicle or excipient. 8. A method for the treatment of neurodegenerative disorders comprising administering to a mammal an effective amount of a compound according to claim 1. 9. A method for the treatment of cerebral ischaemias and craniocerebral trauma comprising administering to a mammal an effective amount of a compound according to claim 1. 10. A method for the treatment of pain, emesis, nausea, glaucoma, asthma, anorexia, convulsions, rheumatism, sedation, and mobility disorders comprising administering to a mammal an effective amount of a compound according to claim 1. 11. A method for the treatment of bacterial or viral infections, autoimmune diseases, inflammatory or autoimmunologically related diseases of the joints of the bone and muscle apparatus, of the internal organs, of the central nervous system, of the sense organs and of the haematogenic system comprising administering to a mammal an effective amount of a compound according to claim 1. 12. A method for the treatment of migraine and spasticity comprising administering to a mammal an effective amount of a compound according to claim 1. 13. The process of claim 6, wherein said trialkysilyl chlorosulphonate is trimethylsilyl chlorosulphonate and said chlorinating agent is phosphorus pentachloride. 14. The process of claim 6, wherein R.sup.43 is selected from the group consisting of chlorine and iodine. 15. The process of claim 6, wherein R.sup.44 is selected from the group consisting of fluorine, chlorine, and bromine. 16. The process of claim 6, wherein said chloroformate is selected from the group consisting of 1-(1-chloro)ethyl chloroformate and methyl chloroformate. 17. The process of claim 6, wherein said alcohol is methanol. 18. The process of claim 6, wherein said reducing agent is sodium cyanoborohydrate. 19. The process of claim 6, wherein R.sup.49 is a halogen. 20. The process of claim 6, wherein said free-radical bromination is performed using N-bromosuccinimide. 21. The process of claim 6, wherein R.sup.12' is tert-butyloxycarbonyl. 22. The process of claim 6, wherein, after removal of the amino protective group, the amino group is reductively alkylated or dialkylated with an aldehyde, ketone, or halide. 23. The process of claim 20, wherein said compound of formula I is esterified. 